Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosana Meyer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biochemistry|December 24, 2025
Human TMIGD1 Promoter Exhibits Robust Activity in Prokaryotic CellsRosana Meyer, Kaneyoshi Yamamoto, Bridget Whelpley, et al.
The Journal of Biological Chemistry|June 8, 2013
c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulationVipul Chitalia, Sowmya Shivanna, Jordi Martorell, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2014
Cell cycle-dependent chromatin shuttling of HBO1-JADE1 histone acetyl transferase (HAT) complexNirodhini S Siriwardana, Rosana Meyer, Andrea Havasi, et al.
Cancer Research|June 4, 2024
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant CancersPatricia J Keller, Elizabeth J Adams, Rentian Wu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biochemistry|December 24, 2025
Human TMIGD1 Promoter Exhibits Robust Activity in Prokaryotic CellsRosana Meyer, Kaneyoshi Yamamoto, Bridget Whelpley, et al.
The Journal of Biological Chemistry|June 8, 2013
c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulationVipul Chitalia, Sowmya Shivanna, Jordi Martorell, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2014
Cell cycle-dependent chromatin shuttling of HBO1-JADE1 histone acetyl transferase (HAT) complexNirodhini S Siriwardana, Rosana Meyer, Andrea Havasi, et al.
Cancer Research|June 4, 2024
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant CancersPatricia J Keller, Elizabeth J Adams, Rentian Wu, et al.
Pageof 1